跳至主要内容
临床试验/JPRN-UMIN000002030
JPRN-UMIN000002030已完成未知

Randomized controlled trial comparing skin-moisturizing agents plus pyridoxine hydrochloride with skin-moisturizing agents alone to prevent hand-foot syndrome in patients received chemotherapy of capecitabine. - Randomized controlled trial comparing skin-moisturizing agents plus pyridoxine hydrochloride with skin-moisturizing agents alone to prevent hand-foot syndrome in patients received chemotherapy of capecitabine.

Shikoku Cancer Center0 个研究点目标入组 20 人开始时间: 2009年6月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Patients with pervious hypersensitive reactions to component 2) regular use of pyridoxine hydrochloride 3)Regular use of levodopa 4) Patients with Grade 1 or higher hand-foot syndrome 5) Patients received chemotherapy including 5Fu 6) Patients judged as the exclusive case by the investigator

研究者

发起方
Shikoku Cancer Center

相似试验